Brief: Forward Pharma Provides Update On Decision Of The Federal Circuit In Appeal Of The U.S. Patent Interference

Forward Pharma A/S

24/10/2018 19:52

Oct 24 (Reuters) - Forward Pharma A/S  FWP.O :
    * FORWARD PHARMA PROVIDES UPDATE ON THE DECISION OF THE FEDERAL CIRCUIT IN
ITS
APPEAL OF THE U.S. PATENT INTERFERENCE
    * FORWARD PHARMA A/S - APPEAL OF EUROPEAN EP2801355 PATENT OPPOSITION
CONTINUES
    * FORWARD PHARMA A/S - FORWARD EXPECTS TO REDUCE OPERATING EXPENSES TO MATCH
CURRENT SITUATION
    * FORWARD PHARMA - U.S. COURT OF APPEALS FOR FEDERAL CIRCUIT AFFIRMED
DECISION OF
PATENT TRIAL AND APPEAL BOARD IN U.S. PATENT INTERFERENCE PROCEEDING
    * FORWARD PHARMA - FEDERAL CIRCUIT AFFIRMED PTAB DECISION IN INTERFERENCE
PROCEEDING BETWEEN CO'S U.S. '871 PATENT APPLICATION & AN ISSUED BIOGEN PATENT

Source text for Eikon:  ID:nGNXbrQ6Kj 
Further company coverage:  FWP.O 

 ((Reuters.Briefs@thomsonreuters.com;))